Christopher M. Melnic
Smith Family, Newton Wellesley Hospital, American Society of Plastic Surgeons, Massachusetts General Hospital
Papers
9
Total Citations
41
H-Index
4
About
Christopher M. Melnic is an emerging leader in orthopaedic surgery, whose research focuses on the intersection of robotic-assisted arthroplasty and value-based care. His work rigorously evaluates whether surgical technology translates into tangible patient benefits, primarily through the lens of the Minimal Clinically Important Difference (MCID). Melnic’s major contributions include landmark comparative studies demonstrating that robotic-assisted unicompartmental and total knee arthroplasties achieve MCID faster than manual techniques, with his 2024 paper on UKA garnering 11 citations. He has extended this analysis to total hip arthroplasty, showing robotic assistance increases the likelihood of meaningful clinical improvement. Beyond clinical outcomes, Melnic is a pioneer in health economics, using time-driven activity-based costing to perform patient-level value analyses of arthroplasty procedures. His 2025 work comparing the cost-effectiveness of UKA versus total knee arthroplasty has been cited 4 times and is critical for shaping value-based healthcare models. Additionally, his survey of the American Association of Hip and Knee Surgeons Young Arthroplasty Group identifies key technical challenges for early-career surgeons, guiding future technological development. With a growing portfolio of highly cited papers, Melnic is shaping the evidence base for how robotics and cost-consciousness can improve patient outcomes in joint replacement surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9